Jefferies Downgrades Option Care Health (OPCH) to Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/9/2026
- S&P closes at record high as soft jobs report eases rate-hike concerns
- US suffers unexpected job losses in July, markets dial back rate hike expectations
- Brent climbs $1 on uncertainty over end to Iran war
- Atlassian results seen as 'game changer' for AI kills software worries
- The Trade Desk hit by Wall St downgrades after disappointing Q2 results, outlook
- Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
- S&P closes at record high as soft jobs report eases rate-hike concerns
- US suffers unexpected job losses in July, markets dial back rate hike expectations
- Atlassian results seen as 'game changer' for AI kills software worries
- Microsoft only US hyperscaler with positive free cash flow as AI capex bites
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
Option Care Health (OPCH) PT Lowered to $34 at Truist Securities
October 31, 2024 6:10 AM EDTTruist Securities analyst David MacDonald lowered the price target on Option Care Health (NASDAQ: OPCH) to $34.00 (from $41.00) while maintaining a Buy rating.
The analyst comments "We reiterate our Buy on OPCH post 3Q where solid results/'24 guide were overshadowed by cautious commentary surrounding... More
Option Care Health (OPCH) PT Lowered to $30 at Deutsche Bank
October 31, 2024 5:57 AM EDTDeutsche Bank analyst Pito Chickering lowered the price target on Option Care Health (NASDAQ: OPCH) to $30.00 (from $36.00) while maintaining a Buy rating.
The analyst comments "OPCH reported 3Q revenue 5% ahead of consensus with gross profit and EBITDA in line with estimates as gross margin and EBITDA margin came in 100 and 40 bps light respectively. Going into the call we believe investors were assessing the more or less in-line 3Q results alongside implied 4Q results for revenue 2.4% ahead of Street with EBITDA 4% below, and how much of that could be from transitory factors like the... More
